EU-Japan Biotech & Pharma Partnering Conference

EU-Japan Biotech & Pharma Partnering Conference | October 5, 2026 | Osaka (JPN)

The EU-Japan Biotech & Pharma Partnering Conference is an international event that will bring together companies, research institutions, and clusters from the biotech and pharma sectors in Europe and Japan. The conference main topics will be drug discovery support, including AI-assisted drug development, regenerative medicine, and digital therapies.

Global collaborations established during this event will lead to the development of innovative biologics. Many projects would not have come to fruition without this openness to co-development. Next-generation drugs, such as antibody-drug conjugates, particularly require a consortium composed of partners offering high-quality solutions for cytotoxic drugs and antibodies. The conference will be held on 5 October 2026 at Hotel Hankyu International in Osaka.

This year’s edition of the event will feature over 200 companies, and the agenda includes over 30 expert presentations. Through this dedicated platform, participants can collaborate directly. The conference provides opportunities to meet potential partners, creating new opportunities for business and research collaboration.

Mabion was represented by Gregor Kawaletz, our Chief Executive Officer. Meeting with Gregor is a great opportunity to learn more about our business development strategy. We offer dedicated biologics development programs for the Japanese market. The in-person event will be preceded by online partner meetings and networking opportunities. See you in Osaka!